Corteva (NYSE:CTVA) Hits New 12-Month Low - Time to Sell?

Key Points

• Corteva shares plunged 82.7%, reaching a new 52-week low of $14.80 after previously closing at $77.65, amid heavy trading volume.
• Despite the selloff, analysts remain generally optimistic: 14 rate the stock a Buy and nine a Hold, producing a “Moderate Buy” consensus and an average price target of $91.90.
• Corteva exceeded quarterly EPS expectations but missed revenue estimates, with sales down 1.2% year over year. The company also declared a quarterly dividend of $0.18 per share, equivalent to a 5.3% annualized yield.

Corteva, Inc. (NYSE:CTVA - Get Free Report) reached a new 52-week low during trading on Thursday. The company traded as low as $14.80 and last traded at $14.04, with a volume of 2826094 shares changing hands. The stock had previously closed at $77.65.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the stock. BMO Capital Markets dropped their price objective on shares of Corteva from $100.00 to $95.00 and set an "outperform" rating on the stock in a research report on Wednesday, September 16th. Mizuho upped their price objective on Corteva from $96.00 to $97.00 and gave the stock an "outperform" rating in a research report on Tuesday, July 14th. Barclays boosted their price objective on shares of Corteva from $84.00 to $91.00 and gave the stock an "overweight" rating in a research report on Thursday, June 11th. Royal Bank Of Canada reiterated an "outperform" rating and issued a $103.00 price target on shares of Corteva in a research report on Wednesday, September 16th. Finally, Citigroup increased their price target on Corteva from $86.00 to $91.00 and gave the stock a "neutral" rating in a report on Thursday, September 17th. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $91.90.

Corteva Trading Down 82.7%

The stock has a market cap of $8.99 billion, a price-to-earnings ratio of 9.30, a PEG ratio of 2.39 and a beta of 0.57. The business has a fifty day simple moving average of $81.90 and a 200 day simple moving average of $81.52. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52.

Corteva (NYSE:CTVA - Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping analysts' consensus estimates of $2.24 by $0.06. The company had revenue of $6.38 billion for the quarter, compared to analyst estimates of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The business's revenue for the quarter was down 1.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, equities analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st were paid a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 5.3%. The ex-dividend date was Tuesday, September 1st. Corteva's payout ratio is currently 47.68%.

Hedge Funds Weigh In On Corteva

Hedge funds and other institutional investors have recently bought and sold shares of the stock. EFG International AG acquired a new stake in Corteva during the 2nd quarter valued at $25,000. Compass Financial Management LLC bought a new stake in shares of Corteva during the second quarter valued at approximately $25,000. Cornerstone Financial Management LLC acquired a new stake in shares of Corteva in the 4th quarter worth approximately $29,000. Elevation Wealth Partners LLC boosted its stake in Corteva by 334.6% during the 2nd quarter. Elevation Wealth Partners LLC now owns 339 shares of the company's stock valued at $29,000 after purchasing an additional 261 shares in the last quarter. Finally, Clearstead Trust LLC acquired a new position in Corteva during the second quarter worth about $31,000. 81.54% of the stock is owned by institutional investors and hedge funds.

Corteva Company Profile

Corteva, Inc is an agriculture-focused company that develops and supplies seed, crop protection and digital agriculture products. Its offerings are designed to help farmers improve crop productivity, manage pests and diseases, and support more efficient and sustainable farming practices.

The company's seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crops, marketed through brands such as Pioneer, Brevant seeds and PhytoGen. Corteva also provides herbicides, insecticides, fungicides, biological products and seed treatments under a range of agricultural brands.

Corteva serves farmers, agricultural retailers and other customers in markets around the world.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.